. >> reporter: two years into her battle with the rare form of cancer, natalee troller and her family think they may be close to something that could help. >> when we found this new medicine, pd 1, we definitely wanted to participate in the trial. >> reporter: pd 1 is part of a new class of experimental drugs. the family and oncologists asked for access. they all said no. >> it was only including people 18 and up, and since i'm only 15, they wouldn't let me in. we asked for compassion et use, but they denied it. >> reporter: compassionate use is a way to use outside of the clinical trials for patients with no other options. natalee and countless others fit that describe. >> agonizing. >> reporter: doug williams leads research, two years ago, the company was working on a therapy. with compassion et use requests pouring in, biogen prepared enough supply to give 5,000 patients if the drug proved to work in clinical trials. >> an individual situation while difficult and heart wrenching has to be weighed against the backdrop of what the ultimate goal is which is to bring these drugs to mar